Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hahn Urges Fixed Terms For US FDA Leaders

Executive Summary

Former commissioner Stephen Hahn and former CDC Director Robert Redfield said leaders of their agencies and NIH  should be selected outside the election schedule. White House task force reviewing political interference with agency science.

You may also be interested in...



US FDA Independence May Be In The Eye Of The Beholder

Former commissioners continue push to move FDA out of HHS, but the alternative could create a different kind of political influence rather than eliminate it.

Former US FDA Commissioners Try To Shake Loose Biden Nomination

Acting commissioner Janet Woodcock, a candidate for the permanent job, and agency’s career staff also garner the group's compliments.

Woodcock Has Big, Quiet Supporter In Her Bid For US FDA Commissioner

Industry groups, along with many rare disease and patient advocacy groups, appear behind the acting commissioner getting the permanent position.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS144083

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel